Suppression of mutant Kirsten-RAS (KRASG12D)-driven pancreatic carcinogenesis by dual-specificity MAP kinase phosphatases 5 and 6

Search results

• Finished

  Regulation of the Oncogenic Potential of Signalling through the Ras/ERK Pathway by Dual-Specificity Phosphates 5 (joint with Universities of Bath and Liverpool and Beatson Institute)

  Hiom, K. (Investigator) & Keyse, S. (Investigator)

  Medical Research Council

  1/09/16 → 30/09/20

  Project: Research

  • Dual Specificity 100%
  • DUSP5 83%
  • MAP Kinase Phosphatase 76%
  • Dual-specificity Phosphatase 5 61%
  • Mitogen-Activated Protein Kinase 55%

• Stress Response Laboratory Programme

  Keyse, S. (Investigator)

  1/10/10 → 30/09/16

  Project: Research

  • Pancreatic Carcinogenesis 100%
  • DUSP6 100%
  • KRAS G12C 100%
  • Dual Specificity 100%
  • MAP Kinase Phosphatase 100%